Green Hygienics Holdings Inc. (GRYN) Offers Ideal Source for Long-term Clinical Research Studies
- Company owns largest single USDA-certified, organic hemp for CBD farm in North America with 824 acres, 400,000 square feet of greenhouse space
- GRYN registered with U.S. Food and Drug Administration in August last year
- Company has capacity to deliver large volume supply chain of premium quality product while remaining compliant for research or regulatory approvals
With a goal of being the leader in both compliance and capabilities in the hemp and cannabinoid supply market, California-based, innovative, technology-driven company Green Hygienics (OTCQB: GRYN) is committed to offering the highest-quality and safest products available. GRYN owns and operates the largest single USDA-certified, organic-hemp farm in North America. The farm property has 824 acres of outdoor cultivation potential and 400,000 square feet of greenhouse space, which supports the Company in this capacity.
In order to participate in long-term clinical research studies, companies must source their materials from the same company over the entire period of the study. This is critically important as it adds credibility and validity to the study results because it maintains consistency and eliminates variables.
When entering into a cooperative research study, it is essential that the Institutional Review Board (“IRB”) take into account the facilities and capabilities of the source (https://nnw.fm/k3dOe). Throughout the entire study, suppliers are expected to show that they can consistently manufacture a quality product and submit sufficient information to ensure the identity, quality, purity, and potency or strength of the investigational drug.
A supply needs to be obtained from a business that has adequate facilities and capabilities, with every variable accounted for and controlled from beginning to end. The supplier must remain in compliance throughout the study while also being capable of meeting demand.
In April of last year, GRYN received its USDA Organic Certification (https://nnw.fm/zv08B). In August, GRYN registered with the U.S. Food and Drug Administration (https://nnw.fm/cNPEb). These strategic moves strengthened the Company’s ability to provide product efficacy to both the pharmaceutical and consumer industries. With foundational accreditations in place, and additional industry first certifications on the horizon, the Company offers research solutions that few others in the industry are capable of. Additionally, Green Hygienics offers a secure, single-origin supply chain of significant size with 400,000 square feet of indoor greenhouse space providing for year-round cultivation.
As other hemp farmers took a step back in 2020, licensed acres dropped by 27% (https://nnw.fm/mJwwI). GRYN, however, will increase its cultivation capacity in 2021 and stay committed to its mission to become the critical supply chain solution from seed to product.
The Company’s commitment and ability to provide both volume and consistency of hemp-derived cannabinoids makes it an ideal supplier for long-term studies within the medical, nutraceutical and pharmaceutical industries.
For more information about this company, visit www.GreenHygienics.com.
NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://nnw.fm/GRYN
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Company owns largest single USDA-certified, organic hemp for CBD farm in North America with 824 acres, 400,000 square feet of greenhouse space
- GRYN registered with U.S. Food and Drug Administration in August last year
- Company has capacity to deliver large volume supply chain of premium quality product while remaining compliant for research or regulatory approvals
With a goal of being the leader in both compliance and capabilities in the hemp and cannabinoid supply market, California-based, innovative, technology-driven company Green Hygienics (OTCQB: GRYN) is committed to offering the highest-quality and safest products available. GRYN owns and operates the largest single USDA-certified, organic-hemp farm in North America. The farm property has 824 acres of outdoor cultivation potential and 400,000 square feet of greenhouse space, which supports the Company in this capacity.
In order to participate in long-term clinical research studies, companies must source their materials from the same company over the entire period of the study. This is critically important as it adds credibility and validity to the study results because it maintains consistency and eliminates variables.
When entering into a cooperative research study, it is essential that the Institutional Review Board (“IRB”) take into account the facilities and capabilities of the source (https://nnw.fm/k3dOe). Throughout the entire study, suppliers are expected to show that they can consistently manufacture a quality product and submit sufficient information to ensure the identity, quality, purity, and potency or strength of the investigational drug.
A supply needs to be obtained from a business that has adequate facilities and capabilities, with every variable accounted for and controlled from beginning to end. The supplier must remain in compliance throughout the study while also being capable of meeting demand.
In April of last year, GRYN received its USDA Organic Certification (https://nnw.fm/zv08B). In August, GRYN registered with the U.S. Food and Drug Administration (https://nnw.fm/cNPEb). These strategic moves strengthened the Company’s ability to provide product efficacy to both the pharmaceutical and consumer industries. With foundational accreditations in place, and additional industry first certifications on the horizon, the Company offers research solutions that few others in the industry are capable of. Additionally, Green Hygienics offers a secure, single-origin supply chain of significant size with 400,000 square feet of indoor greenhouse space providing for year-round cultivation.
As other hemp farmers took a step back in 2020, licensed acres dropped by 27% (https://nnw.fm/mJwwI). GRYN, however, will increase its cultivation capacity in 2021 and stay committed to its mission to become the critical supply chain solution from seed to product.
The Company’s commitment and ability to provide both volume and consistency of hemp-derived cannabinoids makes it an ideal supplier for long-term studies within the medical, nutraceutical and pharmaceutical industries.
For more information about this company, visit www.GreenHygienics.com.
NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://nnw.fm/GRYN
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
